Live Report · Updated January 26, 2026

3M vs Corteva

This page compares 3M and Corteva, exploring their business models, financial performance, and market context in clear terms. It offers a neutral overview of how each company creates value, the sectors they serve, and the strategic factors shaping their directions. Educational content, not financial advice.

This page compares 3M and Corteva, exploring their business models, financial performance, and market context in clear terms. It offers a neutral overview of how each company creates value, the sector...

Comparison Snapshot

Key Financial Metrics

MMM

Metric

CTVA

$84.59B

Market Cap

$49.08B

10.92%

Potential Profit

5.81%

Buy

Analyst Rating

Buy

Why It's Moving

3M Beats Earnings Expectations but Stock Dips on Soft 2026 Guidance.

Q4 profits topped estimates, highlighting resilience in core segments despite market headwinds.
2026 profit guidance underwhelmed analysts, raising flags on growth pace and margin pressures.
Shares tumbled 8.3% over the past week to around $156, contrasting with a positive yearly return.

Sentiment:

🐻Bearish

Corteva Surges on Analyst Upgrades Amid Undervaluation Buzz and Growth Tailwinds

Analysts raised price targets to $81, citing expectations for higher U.S. corn volumes and industry tailwinds that could boost revenues and market share.
Innovation advancements like Vorceed traits and gene editing promise premium pricing and improved margins, framing the stock as 8-10% undervalued at fair value estimates around $78.
Recent 6% 30-day gains reflect momentum from expansion in Latin America and Asia-Pacific, offsetting PFAS class action concerns from a Montana court decision.

Sentiment:

🐃Bullish

3M Beats Earnings Expectations but Stock Dips on Soft 2026 Guidance.

Q4 profits topped estimates, highlighting resilience in core segments despite market headwinds.
2026 profit guidance underwhelmed analysts, raising flags on growth pace and margin pressures.
Shares tumbled 8.3% over the past week to around $156, contrasting with a positive yearly return.

Sentiment:

🐻Bearish

Corteva Surges on Analyst Upgrades Amid Undervaluation Buzz and Growth Tailwinds

Analysts raised price targets to $81, citing expectations for higher U.S. corn volumes and industry tailwinds that could boost revenues and market share.
Innovation advancements like Vorceed traits and gene editing promise premium pricing and improved margins, framing the stock as 8-10% undervalued at fair value estimates around $78.
Recent 6% 30-day gains reflect momentum from expansion in Latin America and Asia-Pacific, offsetting PFAS class action concerns from a Montana court decision.

Sentiment:

🐃Bullish

Investment Analysis

3M

MMM

Pros

3M reported 3.2% organic sales growth in Q3 2025 with a 170 basis point increase in operating margin, driving a 10% adjusted EPS compound growth.
The company maintains strong liquidity with a current ratio of 1.66 and quick ratio of 1.11, indicating solid short-term financial health.
3M’s diverse industrial conglomerate structure supports innovation across multiple sectors, offering broad market exposure and resilience.

Considerations

The stock price is forecasted to decrease about 7.6% by the end of 2025, reflecting some near-term valuation pressure.
3M’s price-to-cash-flow ratio is high at 63.33, suggesting a stretched valuation relative to cash generation.
Despite margin improvements, recent analyst consensus indicates only a moderate buy with some volatility risk and fear sentiment present.

Corteva

CTVA

Pros

Corteva has a strong market position in seeds and crop protection with $16.83B in annual revenue and leadership in agricultural innovation.
The company projects operational EBITDA of $3.6-3.8B for 2025 and expects long-term double-digit CAGR growth through 2027 and beyond.
Corteva is advancing in agri-tech with initiatives in hybrid wheat, biofuels, and gene editing, driving future competitive advantages.

Considerations

Corteva’s valuation ratios such as P/E (42.3x) and price-to-sales (2.9x) are elevated relative to sector averages, indicating limited margin of safety.
The company faces execution risks associated with rapidly evolving agri-tech innovations which might delay growth realisation.
The cyclicality of the agricultural sector and sensitivity to commodity prices could introduce volatility in Corteva’s earnings and stock performance.

Related Market Insights

Tariff-Proof Profits: Why Pricing Power Matters More Than Ever

Discover how companies with strong pricing power protect profits from rising tariffs and inflation. Invest in resilient businesses like 3M, Pool Corp, and PriceSmart with Nemo.